Lantheus Holdings Inc. (NASDAQ:LNTH) traded down 4.1% during trading on Wednesday . The company traded as low as $4.31 and last traded at $4.45, with a volume of 84,799 shares changing hands. The stock had previously closed at $4.64.

LNTH has been the subject of a number of research reports. Zacks Investment Research downgraded Lantheus Holdings from a “buy” rating to a “hold” rating in a research report on Tuesday. Jefferies Group reissued a “buy” rating on shares of Lantheus Holdings in a research report on Wednesday, May 4th. Finally, Robert W. Baird reissued a “hold” rating on shares of Lantheus Holdings in a research report on Monday, April 11th. Four research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average price target of $5.65.

The firm has a 50 day moving average of $3.40 and a 200 day moving average of $2.46. The company’s market capitalization is $146.28 million.

Lantheus Holdings (NASDAQ:LNTH) last posted its earnings results on Tuesday, May 3rd. The company reported $0.34 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.06 by $0.28. The firm earned $76.50 million during the quarter, compared to the consensus estimate of $72.43 million. On average, analysts expect that Lantheus Holdings Inc. will post $0.35 EPS for the current fiscal year.

Lantheus Holdings, Inc is a holding company. The Company, through Lantheus Medical Imaging, Inc, develops, manufactures, sells and distributes diagnostic medical imaging agents and products that assist clinicians in the diagnosis of cardiovascular and other diseases. It operates in two geographical segments: U.S.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.